These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34413435)

  • 1. Understanding fatigue in progressive supranuclear palsy.
    Ahn JH; Song J; Lee DY; Youn J; Cho JW
    Sci Rep; 2021 Aug; 11(1):16926. PubMed ID: 34413435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autonomic Symptoms Correlate with Non-Autonomic Non-Motor Symptoms and Sleep Problems in Patients with Parkinson's Disease.
    Matsubara T; Suzuki K; Fujita H; Watanabe Y; Sakuramoto H; Matsubara M; Hirata K
    Eur Neurol; 2018; 80(3-4):193-199. PubMed ID: 30572329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Non-Motor Symptom Profile of Progressive Supranuclear Palsy.
    Chaithra SP; Prasad S; Holla VV; Stezin A; Kamble N; Yadav R; Pal PK
    J Mov Disord; 2020 May; 13(2):118-126. PubMed ID: 32241079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non motor symptoms in progressive supranuclear palsy: prevalence and severity.
    Radicati FG; Martinez Martin P; Fossati C; Chaudhuri KR; Torti M; Rodriguez Blazquez C; Vacca L; Stocchi F
    NPJ Parkinsons Dis; 2017; 3():35. PubMed ID: 29238748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Dysfunctional Autonomic Function and "Dysfunctional" Fatigue in Drug Naïve Parkinson's Disease.
    Ahn JH; Kim M; Mun JK; Cho Y; Kim JS; Youn J; Kim JS; Cho JW
    J Parkinsons Dis; 2020; 10(2):605-612. PubMed ID: 32250319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an Arabic version of the non-motor symptoms scale in Parkinson's disease.
    Sellami L; Kacem I; Nasri A; Djebara MB; Sidhom Y; Gargouri A; Gouider R
    Neurol Sci; 2016 Jun; 37(6):963-8. PubMed ID: 26932938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular autonomic dysfunction is associated with executive dysfunction and poorer quality of life in progressive supranuclear palsy-Richardson's syndrome.
    Liu P; Chen Y; Wang B; Wu S; Zeng L; Cen Z; Yang D; Wang H; Chen X; Wang L; Ouyang Z; Luo W
    J Clin Neurosci; 2022 Feb; 96():147-153. PubMed ID: 34789416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-motor symptoms in multiple system atrophy: A comparative study with Parkinson's disease and progressive supranuclear palsy.
    Hu WZ; Cao LX; Yin JH; Zhao XS; Piao YS; Gu WH; Ma JH; Wan ZR; Huang Y
    Front Neurol; 2022; 13():1081219. PubMed ID: 36756345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interrelationship between non-motor symptoms in Atypical Parkinsonism.
    Lee CN; Kim M; Lee HM; Jang JW; Lee SM; Kwon DY; Park KW; Koh SB
    J Neurol Sci; 2013 Apr; 327(1-2):15-21. PubMed ID: 23428208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined measurement of plasma cystatin C and low-density lipoprotein cholesterol: A valuable tool for evaluating progressive supranuclear palsy.
    Weng R; Wei X; Yu B; Zhu S; Yang X; Xie F; Zhang M; Jiang Y; Feng ZP; Sun HS; Xia Y; Jin K; Chan P; Wang Q; Gao X
    Parkinsonism Relat Disord; 2018 Jul; 52():37-42. PubMed ID: 29574085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy.
    Sixel-Döring F; Schweitzer M; Mollenhauer B; Trenkwalder C
    Sleep Med; 2009 Apr; 10(4):407-15. PubMed ID: 18945638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy.
    Berganzo K; Tijero B; Somme JH; Llorens V; Sánchez-Manso JC; Low D; Iodice V; Vichayanrat E; Mathias CJ; Lezcano E; Zarranz JJ; Gómez-Esteban JC
    Parkinsonism Relat Disord; 2012 Jan; 18(1):45-8. PubMed ID: 21908227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDQ-8: A Simplified and Effective Tool Measuring Life Quality in Progressive Supranuclear Palsy.
    Li XY; Chen MJ; Liang XN; Yao RX; Shen B; Wu B; Li G; Sun YM; Wu JJ; Liu FT; Yang YJ; Wang J;
    J Parkinsons Dis; 2023; 13(1):83-91. PubMed ID: 36591660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Non-Motor Symptoms Scale for Parkinson's Disease of Persian Version.
    Eghlidos Z; Abolhassanbeigi A; Rahimian Z; Khazraei S; Ostovan VR
    Parkinsons Dis; 2023; 2023():1972034. PubMed ID: 37333718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.
    Martinez-Martin P; Rodriguez-Blazquez C; Abe K; Bhattacharyya KB; Bloem BR; Carod-Artal FJ; Prakash R; Esselink RA; Falup-Pecurariu C; Gallardo M; Mir P; Naidu Y; Nicoletti A; Sethi K; Tsuboi Y; van Hilten JJ; Visser M; Zappia M; Chaudhuri KR
    Neurology; 2009 Nov; 73(19):1584-91. PubMed ID: 19901251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.
    Leiguarda RC; Pramstaller PP; Merello M; Starkstein S; Lees AJ; Marsden CD
    Brain; 1997 Jan; 120 ( Pt 1)():75-90. PubMed ID: 9055799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocturnal disturbances and restlessness in Parkinson's disease: using the Japanese version of the Parkinson's disease sleep scale-2.
    Suzuki K; Miyamoto M; Miyamoto T; Tatsumoto M; Watanabe Y; Suzuki S; Iwanami M; Sada T; Kadowaki T; Numao A; Trenkwalder C; Hirata K
    J Neurol Sci; 2012 Jul; 318(1-2):76-81. PubMed ID: 22534309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias.
    Stamelou M; Diehl-Schmid J; Hapfelmeier A; Kontaxopoulou D; Stefanis L; Oertel WH; Bhatia KP; Papageorgiou SG; Höglinger GU
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1264-8. PubMed ID: 26324212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease.
    Somme J; Gómez-Esteban JC; Tijero B; Berganzo K; Lezcano E; Zarranz JJ
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1230-3. PubMed ID: 23253819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.